Get What's Yours

Share this post

A Second Promising Alzheimer’s Treatment is Announced

philmoeller.substack.com

A Second Promising Alzheimer’s Treatment is Announced

Phil Moeller
May 4, 2023
∙ Paid
Share

There is a flurry of attention today on another promising Alzheimer’s drug. This one is made by Eli Lilly and is called donanemab. The company said yesterday that a clinical trial found that benefits from the medicine were promising enough that it plans to submit its findings to the FDA (U.S. Food & Drug Administration) and other regulators “to achieve …

Keep reading with a 7-day free trial

Subscribe to Get What's Yours to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
Previous
Next
© 2023 Phil Moeller
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing